Lord, S. R., & Harris, A. L. (2023). Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? British journal of cancer, 128(6), 958-966. https://doi.org/10.1038/s41416-023-02204-2
Citace podle Chicago (17th ed.)Lord, Simon R., a Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer 128, no. 6 (2023): 958-966. https://doi.org/10.1038/s41416-023-02204-2.
Citace podle MLA (9th ed.)Lord, Simon R., a Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer, vol. 128, no. 6, 2023, pp. 958-966, https://doi.org/10.1038/s41416-023-02204-2.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..